These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35940556)

  • 1. The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR.
    Steffen J; Ngo J; Wang SP; Williams K; Kramer HF; Ho G; Rodriguez C; Yekkala K; Amuzie C; Bialecki R; Norquay L; Nawrocki AR; Erion M; Pocai A; Shirihai OS; Liesa M
    Mol Metab; 2022 Oct; 64():101566. PubMed ID: 35940556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation.
    Wang Y; Chen C; Chen J; Sang T; Peng H; Lin X; Zhao Q; Chen S; Eling T; Wang X
    Redox Biol; 2022 Jun; 52():102322. PubMed ID: 35504134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
    Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor.
    Takeichi Y; Miyazawa T; Sakamoto S; Hanada Y; Wang L; Gotoh K; Uchida K; Katsuhara S; Sakamoto R; Ishihara T; Masuda K; Ishihara N; Nomura M; Ogawa Y
    Diabetologia; 2021 Sep; 64(9):2092-2107. PubMed ID: 34052855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial protease ClpP supplementation ameliorates diet-induced NASH in mice.
    Choi SE; Hwang Y; Lee SJ; Jung H; Shin TH; Son Y; Park S; Han SJ; Kim HJ; Lee KW; Lee G; Kemper JK; Song HK; Kang Y
    J Hepatol; 2022 Sep; 77(3):735-747. PubMed ID: 35421426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid Hormone Decreases Hepatic Steatosis, Inflammation, and Fibrosis in a Dietary Mouse Model of Nonalcoholic Steatohepatitis.
    Zhou J; Tripathi M; Ho JP; Widjaja AA; Shekeran SG; Camat MD; James A; Wu Y; Ching J; Kovalik JP; Lim KH; Cook SA; Bay BH; Singh BK; Yen PM
    Thyroid; 2022 Jun; 32(6):725-738. PubMed ID: 35317606
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis.
    Nielsen MH; Gillum MP; Vrang N; Jelsing J; Hansen HH; Feigh M; Oró D
    Am J Physiol Gastrointest Liver Physiol; 2023 May; 324(5):G378-G388. PubMed ID: 36852934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained OMA1-mediated integrated stress response is beneficial for spastic ataxia type 5.
    Franchino CA; Brughera M; Baderna V; De Ritis D; Rocco A; Seneca S; Regal L; Podini P; D'Antonio M; Toro C; Quattrini A; Scalais E; Maltecca F
    Brain; 2024 Mar; 147(3):1043-1056. PubMed ID: 37804316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
    Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
    J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A threshold of transmembrane potential is required for mitochondrial dynamic balance mediated by DRP1 and OMA1.
    Jones E; Gaytan N; Garcia I; Herrera A; Ramos M; Agarwala D; Rana M; Innis-Whitehouse W; Schuenzel E; Gilkerson R
    Cell Mol Life Sci; 2017 Apr; 74(7):1347-1363. PubMed ID: 27858084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
    Krishnan A; Abdullah TS; Mounajjed T; Hartono S; McConico A; White T; LeBrasseur N; Lanza I; Nair S; Gores G; Charlton M
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G666-G680. PubMed ID: 28232454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoic acid alleviates schistosomiasis-induced liver fibrosis by upregulating Drp1 phosphorylation.
    Luo J; Shen S
    Acta Trop; 2020 Jun; 206():105449. PubMed ID: 32194067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of hepatic DRP1 exacerbates alcoholic hepatitis by inducing megamitochondria and mitochondrial maladaptation.
    Ma X; Chen A; Melo L; Clemente-Sanchez A; Chao X; Ahmadi AR; Peiffer B; Sun Z; Sesaki H; Li T; Wang X; Liu W; Bataller R; Ni HM; Ding WX
    Hepatology; 2023 Jan; 77(1):159-175. PubMed ID: 35698731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial translation inhibition triggers ATF4 activation, leading to integrated stress response but not to mitochondrial unfolded protein response.
    Sasaki K; Uchiumi T; Toshima T; Yagi M; Do Y; Hirai H; Igami K; Gotoh K; Kang D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33165592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice.
    Quirós PM; Ramsay AJ; Sala D; Fernández-Vizarra E; Rodríguez F; Peinado JR; Fernández-García MS; Vega JA; Enríquez JA; Zorzano A; López-Otín C
    EMBO J; 2012 May; 31(9):2117-33. PubMed ID: 22433842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired OMA1-dependent cleavage of OPA1 and reduced DRP1 fission activity combine to prevent mitophagy in cells that are dependent on oxidative phosphorylation.
    MacVicar TD; Lane JD
    J Cell Sci; 2014 May; 127(Pt 10):2313-25. PubMed ID: 24634514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamin-related protein 1 inhibition reduces hepatic PCSK9 secretion.
    Rogers MA; Hutcheson JD; Okui T; Goettsch C; Singh SA; Halu A; Schlotter F; Higashi H; Wang L; Whelan MC; Mlynarchik AK; Daugherty A; Nomura M; Aikawa M; Aikawa E
    Cardiovasc Res; 2021 Sep; 117(11):2340-2353. PubMed ID: 33523181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.